Mometasone furoate MDI (MF MDI) [clinicaltrials_resource:8fa8b9226d1e243a9aecf671425f1ce7]
intervention [clinicaltrials_vocabulary:intervention]
Mometasone furoate MDI (MF MDI) [clinicaltrials_resource:8fa8b9226d1e243a9aecf671425f1ce7]
Bio2RDF identifier
8fa8b9226d1e243a9aecf671425f1ce7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8fa8b9226d1e243a9aecf671425f1ce7
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
MF 400 mcg via metered dose inhaler twice daily for 52 weeks
intervention name [clinicaltrials_vocabulary:intervention-name]
Mometasone furoate MDI (MF MDI)
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:8fa8b9226d1e243a9aecf671425f1ce7
title
Mometasone furoate MDI (MF MDI)
@en
type
label
Mometasone furoate MDI (MF MDI ...... 8b9226d1e243a9aecf671425f1ce7]
@en